Given GIPs clear ability to act as the most important incretin hormone, it is surprising that it also augments glucagon secretion
Benefits: Improvement of symptoms associated with mold toxicity, biotoxin illness, and exposure to water-damaged buildings Decrease in symptoms related to chronic inflammation and Chronic Inflammatory Response Syndrome (CIRS) Improvement during respiratory failure related to Severe Acute Respiratory Syndrome (SARS) by binding to lung epithelial cells critical for oxygen transfer and surfactant production Reduction in mast cell activation Improved function of gut immune cells in Inflammatory Bowel Disease (IBD) Side-effects: Well-tolerated with few side-effects
Themes continuing from 2025 into 2026 As the obesity market moves into its acceleration phase, several trends that gained traction in 2025 will continue to influence strategies and market dynamics in 2026: As the obesity market evolves, there is a growing recognition that use of obesity medications to maintain weight will be critical for many people
Weak acids like aspirin stay unionized in acidic environments, while weak bases like atropine prefer basic conditions
Hepatic steatosis is due to active lipogenesis and suppression of LCFA oxidation
Proc Natl Acad Sci U S A 2006;103:462833
